The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

Thu, 03rd Feb 2022 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Omega Diagnostics Group PLC, up 24% at 11.76 pence, 12-month range 6.50p-117.98p. The Alva, Scotland-based medical diagnostics company successfully attains a CE mark for its Visitect Covid-19 antigen test. "The company remains in discussions with commercial partners about how best to service the European market and other territories that recognise the CE mark. Omega's commercial offering will be via B2B partners and distributors, and not through a direct-to-consumer strategy," Omega adds.

----------

Creo Medical Group PLC, up 16% at 137.00 pence, 12-month range 116.50p-236.00p. The medical device company, with a focus on surgical endoscopy expects revenue for 2021 to top expectations at "just over" GBP25 million from GBP9.4 million in 2020.

----------

AIM - LOSERS

----------

Actual Experience PLC, down 15% at 12.90p, 12-month range 12.00p-135.00p. The Bath-based analytics-as-a-service company says its annual loss widens to GBP5.9 million in 2021 from GBP5.0 million in 2020. Revenue declines 11% to GBP1.7 million from GBP2.0 million. "Our sales team are engaged, directly or with partners, in multiple sales opportunities. Our clear focus in the coming months is to convert these opportunities to recurring 'continuous improvement' revenue streams," the company explains. Actual Experience accepts that shareholders have been "frustrated" with progress to date. "However, one of these lessons is that sales cycles will typically be longer than initially expected and therefore our planning has been adjusted to accommodate this timing," the company adds. Shares hit their 12-month low on Thursday.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
7 Sep 2020 14:50

IN BRIEF: Omega Diagnostics Completes AbC-19 Self-Test Usability Study

IN BRIEF: Omega Diagnostics Completes AbC-19 Self-Test Usability Study

Read more
3 Sep 2020 18:15

IN BRIEF: Omega Diagnostics Reports CE-Mark Of Mologic Covid-19 Test

IN BRIEF: Omega Diagnostics Reports CE-Mark Of Mologic Covid-19 Test

Read more
3 Sep 2020 11:38

Omega prepares to manufacture Mologic Covid-19 test

(Sharecast News) - Medical diagnostics company Omega announced on Thursday that it has CE-marked Mologic's lateral flow antibody test for Covid-19, for sale under its 'Visitect' brand.

Read more
21 Aug 2020 10:18

WHO Prequalification For Omega Diagnostics' HIV Advanced Disease Test

WHO Prequalification For Omega Diagnostics' HIV Advanced Disease Test

Read more
19 Aug 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
30 Jul 2020 13:23

Omega Diagnostics up on CE-marking of Covid test

(Sharecast News) - Omega Diagnostics updated the market on the work of the UK Rapid Test Consortium in the development of a Covid-19 'Abc-19' lateral flow antibody test on Thursday, reporting that lead partner Abingdon Health has CE-marked the test for professional use.

Read more
14 Jul 2020 16:11

Omega Diagnostics Swings To Loss In Full Year Despite Revenue Growth

Omega Diagnostics Swings To Loss In Full Year Despite Revenue Growth

Read more
8 Jul 2020 15:51

IN BRIEF: Omega Diagnostics Issues 54% Of Shares Under Open Offer

IN BRIEF: Omega Diagnostics Issues 54% Of Shares Under Open Offer

Read more
8 Jul 2020 10:01

Omega Diagnostics completes open offer to raise £11m

(Sharecast News) - Omega Diagnostics reported the results of its open offer on Wednesday, netting gross proceeds from its recent fundraising of £11m before expenses.

Read more
2 Jul 2020 10:32

IN BRIEF: Omega Diagnostics Near Antibody Test Green Light In India

IN BRIEF: Omega Diagnostics Near Antibody Test Green Light In India

Read more
2 Jul 2020 09:26

Omega Diagnostics' ELISA antibody test gets approval in India

(Sharecast News) - Medical diagnostics company Omega revealed on Thursday that its CE-Marked Mologic ELISA antibody test had been approved for Covid-19 testing in India.

Read more
29 Jun 2020 16:43

IN BRIEF: Omega Diagnostics Reports Progress At Virus Consortium

IN BRIEF: Omega Diagnostics Reports Progress At Virus Consortium

Read more
29 Jun 2020 11:40

Omega upbeat on Covid test consortium developments

(Sharecast News) - Omega Diagnostics updated the market on an announcement from the UK Rapid Test Consortium (UK-RTC) on Monday, developing a Covid-19 lateral flow antibody test that could be used by people in their homes.

Read more
19 Jun 2020 10:56

Omega Diagnostics To Raise Up To GBP11 Million To Develop Products

Omega Diagnostics To Raise Up To GBP11 Million To Develop Products

Read more
9 Jun 2020 14:16

Omega expands Covid testing work, stops allergy development

(Sharecast News) - Omega Diagnostics updated the market on a number of fronts on Tuesday, announcing the signing of a longer-term supply agreement with Mologic, first orders for the Covid-19 'ELISA' test, and the signing of an additional material transfer agreement with Mologic.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.